| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/21/1999 | US5955621 Recovery of Taxanes from conifers |
| 09/21/1999 | US5955612 Fluorescent labeling reagents |
| 09/21/1999 | US5955594 Nucleic acids encoding proteins for early liver development |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955592 Nucleotide and amino acid sequences; for diagnosis of susceptiblity to cancer or diabetes |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955584 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 09/21/1999 | US5955582 For immunoassay diagnosis and monitoring of conditions like diabetes |
| 09/21/1999 | US5955449 Diagnosis and treatment of bacterial dysentery |
| 09/21/1999 | US5955437 Use of an anticoagulant as a diagnostic agent |
| 09/21/1999 | US5955379 Biosensor device and method |
| 09/21/1999 | US5955377 Screening for compounds in a sample using transmitted or reflective light which measures mass change on surface of device |
| 09/21/1999 | US5955376 Collecting particles onto porous surface, then nonspecific immobilization of diffused macromolecular species to surface within distance of one to ten diameters of the particle, detecting physical or chemical characteristic of molecule |
| 09/21/1999 | US5955374 Method of detection of bilirubin in urine on an automated analyzer |
| 09/21/1999 | US5955372 Detection of concrete deterioration by staining |
| 09/21/1999 | US5955371 Blood collection tube with granulated particles of fluoride salt and anticoagulant; particle sizes range from 130 to 350 mesh; for more accurate and consistent analysis results |
| 09/21/1999 | US5955370 Urine adulteration test method |
| 09/21/1999 | US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins |
| 09/21/1999 | US5955359 Method of growing granulocytic ehrlichiae of the Ehrlichia phagocytophila genogroup in promyelocytic leukemia cell culture, and preparing antigens and vaccines of said granulocytic ehrlichiae |
| 09/21/1999 | US5955358 Adjusting nucleic acids to increase binding of encoded antibody by randomly incorporating complementarity determining regions; enhancing immune response |
| 09/21/1999 | US5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences |
| 09/21/1999 | US5955351 Self-contained device integrating nucleic acid extraction amplification and detection |
| 09/21/1999 | US5955346 Variants of human prolactin and human placeatal lactogen |
| 09/21/1999 | US5955342 Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
| 09/21/1999 | US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 09/21/1999 | US5955337 Lyase enzyme which can be used to screen fungicidal compounds |
| 09/21/1999 | US5955335 First covalently bonding crosslinking reagent having amino-reactive group of aldehyde, ester, halogenide, epoxide, imine or isocyanate to surface; then bonding reagent with biomaterial; simplification; stable products |
| 09/21/1999 | US5955318 Reagents and methods useful for controlling the translation of hepatitis GBV proteins |
| 09/21/1999 | US5955314 Nucleotide sequence that codes polypeptide controller of g-protein signaling; prevention and diagnosis of cancer; anticarcinogenic agents; antiinflammatory agents; therapy of nervous system disorders; antisense agents |
| 09/21/1999 | US5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955306 Nucleotide sequences that codes for a polypeptide that is useful in the development of screening methods, therapeutics and diagnostic tools related to obesity |
| 09/21/1999 | US5955304 DivIB |
| 09/21/1999 | US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents |
| 09/21/1999 | US5955295 Micro lysis-analysis process to measure cell characteristics and diagnose diseases |
| 09/21/1999 | US5955293 Immunoassay by contacting sample with capture agent bound to solid support, then with monoclonal antibody, detecting presence or absence of binding |
| 09/21/1999 | US5955291 Antibodies against extrcellular domain; useful as a diagnostic tool of tumor formation; monitoring of wound healing; imaging agents |
| 09/21/1999 | US5955289 Assays for nongenotoxic, chemical carcinogens |
| 09/21/1999 | US5955287 Diagnostic immunoassay by heating sample, adding two antibodies, detecting blocking of binding of second antibody to first by absence of precipitation of first antibody |
| 09/21/1999 | US5955285 Method of identifying individuals at risk of suffering from cerebral amyloidosis |
| 09/21/1999 | US5955284 Screening for serine protease inhibitors by using; hybridization detecting complex |
| 09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
| 09/21/1999 | US5955281 Screening cells for mutant forms of receptors or signal transduction proteins by transfecting cells with dna library, incubating cells with little or no agonist, measuring levels of marker |
| 09/21/1999 | US5955280 Determining sensitivity of two distinct proteins to each other in cells that are mating by detecting expression of reporter genes |
| 09/21/1999 | US5955271 Reverse transcription and amplification in same heat stable reaction vessel; vessel has interior coated with chemical which binds label on hybridization partner |
| 09/21/1999 | US5955269 Methods of screening foods for nutraceuticals |
| 09/21/1999 | US5955264 Rapid and simple selection of complementary dna encoding proteinmutations which reduce binding; using expression vectors in host cells exposed to selection agents |
| 09/21/1999 | US5955263 Detecting wild type human oncogene protein in cell; diagnosis and cancer treatment; anticarcinogenic agents |
| 09/21/1999 | US5955262 Enzyme coupled hybridization probe for rapid and efficient detection of nucleotide sequence in sample |
| 09/21/1999 | US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample |
| 09/21/1999 | US5955259 Contacting ion channel with test compound and polpeptide havng src homology 3 domain of tyrosine kinase, measuring binding as indicator |
| 09/21/1999 | US5955150 Method for testing materials for use in electroless plating |
| 09/21/1999 | US5955090 Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins |
| 09/21/1999 | US5955089 Streptococcus for vaccines |
| 09/21/1999 | US5955079 Composition comprising high molecular weight primary carrier, secondary carrier comprising t-dependent antigen conjugated to primary carrier, having enhanced antibody response to both carriers |
| 09/21/1999 | US5955074 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/21/1999 | US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
| 09/21/1999 | US5955056 Assay for monitoring and assessing the mutagenic potential of agents which involves creating transgenic non-human animals carrying a test dna sequence or sequences that can be quickly recovered and examined for mutations following exposure to one |
| 09/21/1999 | US5955027 Reagent composition, testing piece, and assay kit |
| 09/21/1999 | US5955026 Detecting the thickness of fibrin polymer using an optical device |
| 09/21/1999 | US5954954 Method and apparatus for determination of analyte concentration |
| 09/21/1999 | US5954923 Electromagnetic field perturbation sensor and methods for measuring water content in sheetmaking systems |
| 09/21/1999 | US5954922 Method and apparatus for determining pulp permeability and compressibility for controlling papermaking process |
| 09/21/1999 | CA2181189C Mesoscale polynucleotide amplification devices |
| 09/21/1999 | CA2174971C Neural axon outgrowth modulators |
| 09/21/1999 | CA2123235C Novel n-alkylacridan carboxyl derivatives useful for chemiluminescent detection |
| 09/21/1999 | CA2106211C Method of detecting foreign matter in pulp suspension and device for detecting the same |
| 09/21/1999 | CA2073741C Thromboplastin extract, reagent, and preparation thereof |
| 09/21/1999 | CA2072331C Sampling device and sample adequacy system |
| 09/20/1999 | CA2226394A1 A method for influencing chromosome stability |
| 09/16/1999 | WO1999046657A2 Systems and methods for storing, retrieving, and manipulating data in medical processing devices |
| 09/16/1999 | WO1999046600A1 Detection of analytes by fluorescent lanthanide chelates |
| 09/16/1999 | WO1999046599A1 Method for counting leukocytes and leukocyte counter |
| 09/16/1999 | WO1999046598A1 Methods and tools for identifying compounds which modulate atherosclerosis by impacting ldl-proteoglycan binding |
| 09/16/1999 | WO1999046597A1 Assay of igfbp complex |
| 09/16/1999 | WO1999046596A1 Light detecting optical device |
| 09/16/1999 | WO1999046595A1 High-throughput screening assays for modulators of nucleic acid topoisomerases |
| 09/16/1999 | WO1999046594A2 C-myc coding region determinant-binding protein (crd-bp) |
| 09/16/1999 | WO1999046593A1 Systems and methods for monitoring and analyzing operation of medical processing devices |
| 09/16/1999 | WO1999046592A1 Regulation of the cell cycle by sterols |
| 09/16/1999 | WO1999046591A2 Integrated assay device and methods of production and use |
| 09/16/1999 | WO1999046588A1 Apparatus for automatically measuring minute membrane potential |
| 09/16/1999 | WO1999046587A1 Water quality measuring apparatus with a sensing wafer clamped between two o-rings |
| 09/16/1999 | WO1999046585A1 Heated electrochemical cell |
| 09/16/1999 | WO1999046582A1 Assay device, composition, and method of optimizing assay resolution |
| 09/16/1999 | WO1999046576A1 Test apparatus and method of measuring mar resistance of film or coating |
| 09/16/1999 | WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/16/1999 | WO1999046487A1 Method for determining the condition of engine oil based on tbn modeling |
| 09/16/1999 | WO1999046408A1 Detection of neoplasia by analysis of saliva |
| 09/16/1999 | WO1999046406A1 Gata-3-expression in human breast carcinoma |
| 09/16/1999 | WO1999046401A2 14-3-3 proteins used as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen |
| 09/16/1999 | WO1999046390A1 Chitinase chitin-binding fragments |
| 09/16/1999 | WO1999046385A2 Compositions and methods for the treatment and prevention of metastatic disorders |
| 09/16/1999 | WO1999046382A1 Chondrosarcoma associated genes |
| 09/16/1999 | WO1999046381A2 Human fgf gene and gene expression products |
| 09/16/1999 | WO1999046380A2 Human membrane spanning proteins |
| 09/16/1999 | WO1999046375A2 Human nucleic acid sequences from prostate tissue |
| 09/16/1999 | WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue |
| 09/16/1999 | WO1999046367A2 Methods of diagnosis and triage using cell activation measures |